Press release
mRNA Therapeutics Market to Reach USD 45.40 billion by 2030, SWOT Analysis including Key players - BioNtech, Translate Bio, Aros Therapeutics, AstraZeneca, Pfizer, Sangamo therapeutics, CureVac
The report delves into the regional analysis of the global mRNA therapeutics market, providing a detailed assessment of key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It examines factors such as government initiatives, regulatory frameworks, healthcare infrastructure, and reimbursement policies that influence market growth in each region.
Furthermore, the report profiles leading companies operating in The report profiles leading companies operating in the mRNA therapeutics market, highlighting their key strategies, product portfolios, and recent developments to provide a comprehensive understanding of the competitive landscape.
Ask here for Sample Copy: https://www.snsinsider.com/sample-request/2671
Market Overview
The mRNA Therapeutics Market size was valued at USD 39.40 billion in 2022 and is expected to grow at USD 45.40 billion by 2030 and grow at a CAGR of 1.5% over the forecast period of 2023-2030.
mRNA therapeutics have emerged as a groundbreaking technology in the field of medicine, offering immense potential to revolutionize the treatment of various diseases. This innovative approach utilizes messenger RNA (mRNA) molecules to instruct cells in the body to produce therapeutic proteins, enabling targeted and personalized treatments.
The mRNA therapeutics market has witnessed significant growth in recent years, driven by several factors. Firstly, advancements in mRNA synthesis and delivery technologies have overcome previous challenges associated with stability and efficient delivery into cells. This has paved the way for the development of a wide range of mRNA-based therapies targeting various diseases, including cancer, infectious diseases, genetic disorders, and rare diseases.
One of the key advantages of mRNA therapeutics is their ability to provide precise and customizable treatments. Unlike traditional pharmaceuticals that often target a specific protein or pathway, mRNA therapies can be designed to produce any desired protein within cells. This flexibility allows for tailored treatments based on individual patient characteristics, potentially leading to improved Furthermore, mRNA-based therapies have shown promising results in clinical trials, indicating their potential to revolutionize the field of medicine and provide new treatment options for patients.
Major Players Listed in the Report are as Follows:
BioNtech AG, Translate Bio, Inc, Aros Therapeutics, AstraZeneca, Pfizer plc, Sangamo therapeutics, CureVac NV, Ethris GMBh, Etherna Immunotherapies., Crisper Therapeutics.
Key Market Segmentation:
By Application:
• Rare genetic disease
• Respiratory disease
• Infectious disease
By Type:
• Prophylactic vaccines
• Therapeutic Vaccines
• Therapeutic Drugs
By End User:
• Hospitals and clinics
• Research Organizations
Need Customized Report as per Your Business Requirement Ask Here: https://www.snsinsider.com/enquiry/2671
Reginal Analysis
MRNA Therapeutics Market report delves into the regional analysis of the MRNA Therapeutics market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It examines the market dynamics specific to each region and identifies lucrative opportunities for market players.
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 MRNA Therapeutics Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter's 5 forces model
Chapter 7 PEST Analysis
Chapter 8 MRNA Therapeutics Market Segmentation, By Application
Chapter 9 MRNA Therapeutics Market Segmentation, By Type
Chapter 10 MRNA Therapeutics Market Segmentation, By End User
Chapter 11 Regional Analysis
Chapter 12 Company profile
Chapter 13 Competitive Landscape
Chapter 14 Use Case and Best Practices
Chapter 15 Conclusion
Buy Complete Research Report: https://www.snsinsider.com/checkout/2671
Contact Us:
Akash Anand - Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com/
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Therapeutics Market to Reach USD 45.40 billion by 2030, SWOT Analysis including Key players - BioNtech, Translate Bio, Aros Therapeutics, AstraZeneca, Pfizer, Sangamo therapeutics, CureVac here
News-ID: 3276807 • Views: …
More Releases from SNS Insider
Video Surveillance Market Analysis Unveils Insights for Growth and Development
Video Surveillance Market Scope and Overview
The Video Surveillance Market has seen significant growth over the past few decades, driven by advancements in technology and an increasing need for security across various sectors. Video surveillance systems, once primarily used for security purposes, have now expanded their applications to include monitoring, analysis, and even preventive measures in various industries. This report provides a comprehensive analysis of the video surveillance market, covering its…
Electric Scooter Battery Market Charges Ahead, Propelling Sustainable Urban Mobi …
The Global Electric Scooter Battery Market is experiencing a remarkable surge, fueled by the rising demand for eco-friendly and convenient transportation solutions in urban environments. As cities around the world grapple with traffic congestion, air pollution, and the need for sustainable mobility, the electric scooter battery market is poised to play a pivotal role in shaping the future of urban transportation. According to a comprehensive market research report, the electric…
Solar-Powered Vehicle Market Accelerates Towards a Sustainable Future, Projected …
The Global Solar-Powered Vehicle Market is rapidly gaining momentum, driven by the urgent need to combat climate change and reduce greenhouse gas emissions. As the world transitions towards a greener and more sustainable future, the adoption of solar-powered vehicles is emerging as a game-changer in the automotive industry. According to a comprehensive market research report, the solar-powered vehicle market, valued at $1.27 billion in 2023, is expected to reach a…
Tilt Sensor Market to Surpass USD 410.35 million with Highest CAGR of 8.28% by 2 …
Market Size & Growth Analysis
The Tilt Sensor Market experienced significant growth, with a valuation of USD 217.15 million in 2023, and is projected to surge to USD 410.35 million by 2031, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.28% during the forecast period spanning 2024 to 2031. This remarkable expansion can be attributed to several key growth drivers propelling the market forward. Firstly, increasing industrial automation across various…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
